Haemophilus influenzae type b purpura fulminans treated with hyperbaric oxygen

Area of Science:

• Pediatrics
• Infectious Diseases
• Hyperbaric Medicine

Background:

• Purpura fulminans is a rare, life-threatening condition characterized by rapid-onset skin necrosis and disseminated intravascular coagulation.
• Haemophilus influenzae type b (Hib) is a significant cause of bacterial meningitis and invasive infections in young children.
• Conventional treatment for purpura fulminans includes antibiotics, anticoagulation, and supportive care.

Observation:

• A 4-month-old infant presented with purpura fulminans secondary to Haemophilus influenzae type b infection.
• The infant received standard medical care for purpura fulminans.
• Adjunctive therapy with hyperbaric oxygen was administered to the patient.

Findings:

• The infant demonstrated a complete recovery from purpura fulminans.
• Hyperbaric oxygen therapy, as an adjunct to conventional treatment, appeared to contribute to the positive outcome.
• No adverse effects were noted during or after hyperbaric oxygen treatment.

Implications:

• This case suggests that hyperbaric oxygen may be a beneficial adjunctive therapy for purpura fulminans, particularly in cases caused by Haemophilus influenzae type b.
• Further research is warranted to establish the efficacy and safety of hyperbaric oxygen in managing purpura fulminans.
• The findings may inform treatment protocols for severe pediatric infections and associated complications.